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DOI: 10.1039/c0jm02124eBiomolecule-mediated ZnO synthesis has great potential for the tailoring of ZnO morphology for
specific application in biosensors, window materials for display and solar cells, dye-sensitized solar cells
(DSSCs), biomedical materials, and photocatalysts due to its specificity and multi-functionality. In this
contribution, the effect of a ZnO-binding peptide (ZnO-BP, G-12: GLHVMHKVAPPR) and its
GGGC-tagged derivative (GT-16: GLHVMHKVAPPRGGGC) on the growth of ZnO crystals
expressing morphologies dependent on the relative growth rates of (0001) and (1010) planes of ZnO
have been studied. The amount of peptide adsorbed was determined by a depletion method using
oriented ZnO films grown by Atomic Layer Deposition (ALD), while the adsorption behavior of G-12
and GT-16 was investigated using XPS and a computational approach. Direct evidence was obtained to
show that (i) both the ZnO-BP identified by phage display and its GGGC derivative (GT-16) are able to
bind to ZnO and modify crystal growth in a molecule and concentration dependent fashion, (ii) plane
selectivity for interaction with the (0001) versus the (1010) crystal planes is greater for GT-16 than G-12;
and (iii) specific peptide residues interact with the crystal surface albeit in the presence of charge
compensating anions. To our knowledge, this is the first study to provide unambiguous and direct
quantitative experimental evidence of the modification of ZnO morphology via (selective and non-
selective) adsorption–growth inhibition mechanisms mediated by a ZnO-BP identified from phage
display libraries.Introduction
The realization of the ZnO era in the electronics and optoelec-
tronics industries may be possible if the excellent electrical and
optical properties of ZnO,1–3 from sub-nanometre quantum dots
to micrometre sized crystals, can be exploited. The challenges
ahead can be generally classified into four areas: crystallinity and
purity of ZnO; doping effectiveness and efficiency; size,
morphology and functional structure assembly; and, last but not
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80 | J. Mater. Chem., 2011, 21, 80–89morphology control has been given much attention since the
successful application of ZnO in many instances relies on its
shape- and size-dependent properties.2 Highly crystalline ZnO
crystals with diverse nanostructures, from simple to hierarchical,
have been produced by vapor route synthesis.1,2,4–12 However, the
solution route offers a simpler, low cost scale-up, ‘‘green’’, and
versatile alternative for ZnO synthesis.
The morphology of ZnO synthesized in solution (aqueous and
non-aqueous) can be tuned via three distinct approaches: (i) the
use of structure-directing agents (SDAs); (ii) the retention of
ZnO precursor structures, such as layered basic zinc salt (LBZS),
with ZnO formation realized by thermal decomposition; and (iii)
a localized-reaction approach such as sonochemical and micro-
wave-assisted synthesis. The most commonly used approach is
that involving SDAs ranging from simple molecules, such as
amines13–16 and anionic species,17–21 to polymers (DBCP,22–29
PVP,30–42 PAM,29 and PAH43) and biomolecules.44–52 The SDAs
have been shown to affect the morphology of ZnO by imposition
of effects on nucleation and/or growth of the crystals. Among
these SDAs, biomolecules have received little attention in ZnO
synthesis because of their complexity, high cost, and sensitivity to
reaction conditions. Nonetheless, the use of biomolecules to
direct ZnO synthesis is attractive for a number of reasons. The
first is the potential of biomolecules to direct ZnO formationThis journal is ª The Royal Society of Chemistry 2011
under mild reaction conditions.53,54 Secondly, some biomolecule-
directed syntheses have been shown to impose exquisite control
on ZnO morphology/structure;44–46,48,50,51,55 improve ZnO
crystallinity;50 template ZnO formation;47,49,52,56 catalyze ZnO
formation;57,58 and also suppress ZnO formation.44,45 These
diverse effects can possibly be used to tune the morphology/
structure-related properties of ZnO and thus its applications.
Thirdly, biomolecules show remarkable recognition capabilities,
functional specificity and multi-functional characteristics which
may contribute to high efficiency and accuracy in ZnO structure
tailoring. Finally, there is an infinite reservoir of biomolecules
with highly diverse functionalities that can be explored and
discovered.53
Some biomolecules have been shown to influence ZnO
morphology. As an example, ZnO films have been formed on
substrates in the presence of histidine and/or its dipeptides,
however, when these biomolecules were absent, discrete ZnO
microcrystals were obtained.44,45 In another study, the change of
reactant concentrations, including variation of histidine
concentration, generated ZnO particles with diverse morphol-
ogies including microrods, flowers, and microshells.48 ZnO
microshells can also be produced by the use of cysteine59 while
the use of a urease enzyme has been shown to produce nanoshells
with potentially tunable diameters.47 The transformation of ZnO
particles from spheres to hexagonal plates and ellipsoids has been
achieved by progressive reduction of the chain length of silk
fibroin added.56 Hexagonal plates have also been synthesized
using gelatine50,51 and Arabic gum55 from reactions where
hexagonal pellets or irregularly shaped crystals were typically
formed respectively. In addition, a three-dimensional interwoven
mesoporous fibrillar ZnO structure has been obtained using
eggshell membrane as a template.49,52 With the exception of
studies involving amino acids and dipeptides, biomolecules that
have been used in the study of ZnO formation are mainly
complex macromolecules and, in some cases, their reactivity is
determined by their multiple active sites and secondary/tertiary
conformations. Thus many of the ‘‘wonders’’ that occur in their
presence are created in a ‘‘black box’’.
An alternative approach for the rational design of simpler
biomolecules for the generation of materials with novel form and
for the study of biomolecule-mediated interactions is application
of the combinatorial display method where short peptides (7-mer
or 12-mer) that have affinity towards the surface of a metal or
metal oxide can be identified. Although there are limitations
to this approach,60,61 a number of metal-binding
peptides (M-BPs)62–65 and metal oxide-binding peptides
(MO-BPs)46,58,66–70 have been identified that have either been
shown to have an affinity for the surface they were isolated from
or have been shown to influence the growth of their respective
metal or metal oxide. The identification of ZnO-binding peptides
(ZnO-BPs) and understanding how they adhere to the surface of
ZnO is potentially useful for the construction of artificial
biomaterials, medical implants, and biosensors where biocom-
patibility is required. Peptides could also be used to control
crystal growth, for example, producing ZnO with high surface to
volume ratio for applications as solar cells, catalysts and
sensors.1–3,71
Application of the combinatorial phage display method iden-
tified a ZnO-BP, EAHVMHKVAPRP (EM-12) and its GGGSCThis journal is ª The Royal Society of Chemistry 2011derivative, EAHVMHKVAPRP–GGGSC was found to catalyze
ZnO formation from a stable Zn(OH)2 sol.
58 This EM12–GGGSC
peptide derivative was further attached to a genetically modified
collagen-like triple helix template to generate ZnO nanowires.72
EM-12 has also been used to assist in the immobilization of green
fluorescent protein (GFP) on ZnO surfaces with a 15 amino acid
linker (GGGSAGSAASGSGEF) being used to tether the protein
to the ZnO-BP.73 The interaction between the EM-12 peptide and
the ZnO surface has been shown to occur via electrostatic inter-
action with the single lysine present in the peptide contributing
significantly and surrounding non-charged residues also being
influential. Others have isolated a ZnO-BP with 67% sequence
similarity to EM-12, GLHVMHKVAPPR (G-12).46 The authors
have shown that a transformation of ZnO from bipyramidal
hexagonal rods to hexagonal plates occurs when the concentration
of a GGGC tagged derivative of G-12, GLHVMHKVAPRP–
GGGC (GT-16) in a zinc nitrate–hexamethylenetetramine
(Zn(NO3)2–HMTA) reaction system is increased.
46 The authors
propose that GT-16 inhibited the growth of ZnO along its c-axis
by selectively adsorbing on the (0001) plane of ZnO based on three
pieces of indirect evidence: (i) the GT-16 concentration dependent
reduction of the aspect ratio of ZnO, (ii) the (0001) plane of ZnO
crystal was flat and well-defined, and (iii) addition of GT-16 to the
reaction had no effect on the diameter of ZnO.
Hitherto, evidence for the ability of biomolecules to tune ZnO
morphology has been gained for single amino acids,44,45,48,59 short
peptides,44,45,46,58 through to complex macromolecules such as
proteins.47,50,51,57,72,74 However, the focus of research in this area
has been generally application-driven, and a mechanistic
understanding of biomolecule-mediated ZnO formation remains
incomplete. It has been postulated widely that the suppression of
ZnO growth along its c-axis by biomolecules (also by
many synthetic polymers/molecules) may be due to the adsorp-
tion of growth-inhibiting additives on the (0001) plane of ZnO
via electrostatic interactions13,18–20,46,50,75 or growth-promoting
additives on complementary planes21,76,77 but no direct
measurement of the interactions has been made.
Recently a theory of competitive adsorption–nucleation to
explain changes of ZnO aspect ratio in the presence of poly-
peptides has been developed.78 According to this theory, the
adsorption of polypeptides on the (0001) plane of ZnO would
reduce the surface energy of the plane which in turn reduces the
aspect ratio of ZnO crystals formed. The calculated aspect ratio-
to-polypeptide concentration relationship fitted extremely well
with the experimental data from Tomczak et al.46 However, direct
empirical evidence has not been provided to support biomolecule
(that when present have altered ZnO morphology) adsorption on
crystal plane(s) of ZnO. The interaction of specific amino acids
such as lysine and alanine with ZnO single crystal planes has been
studied,79,80 but their effect on ZnO morphology/growth has not
yet been identified.45 As other examples, the interaction of tryp-
tophan,81 bovine serum albumin,82 and plasma proteins83 with
ZnO has also been studied experimentally using ZnO nano-
particles mainly characterized in terms of size,81,83 shape,81,83 and z
potential.83 Crystallographic information relating to the surfaces
of these nanoparticles exposed to biomolecules was not provided.
In this study, we sought to obtain direct evidence for the
selective adsorption of a ZnO-BP (G-12) and its GGGC tagged
derivative (GT-16) on specific ZnO crystal plane(s) and relatedJ. Mater. Chem., 2011, 21, 80–89 | 81
these data to changes in crystal morphology. The experiments
and molecular dynamics simulations were designed to provide
direct evidence and provide answers to the following questions:
(i) are the G-12 and GT-16 peptides able to bind to ZnO and/or
modify crystal growth? (ii) is peptide binding dependent on ZnO
crystal-plane and peptide-sequence? (iii) can we elucidate the
molecular level interactions between peptide and ZnO?
Materials and methods
Zinc nitrate hexahydrate (Zn(NO3)2$6H2O), hexamethylenetet-
ramine (HMTA, C6H12N4), sodium monophosphate (NaH2PO4),
sodium phosphate dibasic (Na2HPO4), sodium chloride (NaCl),
trifluoroacetic acid (TFA, C2HF3O2), thioanisole (C7H8S),
3,6-dioxa-1,8-octanedithiol (DODT, C6H14O2S2), 1 M hydro-
chloric acid (HCl), and a zinc atomic absorption standard solu-
tion (1000 ppm) were purchased from Sigma-Aldrich; diethyl
ether was purchased from Fisher Scientific; O-benzotriazole-
N,N,N0,N0-tetramethyl-uronium-hexafluoro-phosphate (HBTU)
and all Fmoc-protected amino acids required for peptide synthesis
were purchased from CEM Corporation while the arginine- and
cysteine-preloaded Wang resins were obtained from Nova-
biochem. All chemicals were used without further treatment.
Distilled, deionized water (ddH2O) with conductivity less than
1 mS cm1 was used in all experiments.
Solid phase peptide synthesis
G-12 and GT-16 were prepared by solid phase methods using
a microwave-assisted solid phase peptide synthesizer (CEM
Corporation) via Fmoc chemistry.84 Wang resins were used as the
solid support. The following side chain protections were used:
Pbf for arginine; Trt for cysteine and histidine; and Boc for
lysine. The couplings, via a O-benzotriazole-N,N,N0,N0-tetra-
methyl-uronium-hexafluoro-phosphate (HBTU) condensation
agent, were single except for arginine where a double coupling
was used. The cleavage of the peptide from the resin and the
deprotection of side chains were achieved in one step by treating
the peptide resin with cleaving agent containing trifluoroacetic
acid, thioanisole, ddH2O, and 3,6-dioxa-1,8-octanedithiol
(DODT). The cleaved peptides were re-precipitated in chilled
diethyl ether, washed three times with the same solvent prior to
lyophilisation at 70 C using a Virtis-110 freeze-dryer. The
purity of the lyophilized peptides was analyzed with a Dionex
HPLC equipped with a UV detector (set at 214 nm) and a Jupiter
4u Proteo 90A C12 Reverse Phase column (Phenomenex). The
purity of G-12 and GT-16 was determined as 95% and 88%
respectively. The molecular weight (Mw) of the peptides was
measured using a Bruker UltraflexIII TOF/TOF mass spec-
trometer and analyzed with Daltonics flexAnalysis software. The
Mw of the peptides was confirmed to be on target where the
calculated Mw for G-12 and GT-16 were 1341.6 g mol
1 and
1615.9 g mol1 respectively while their measured Mw were
1341.7 g mol1 and 1615.8 g mol1 respectively.
ZnO synthesis and kinetic studies
100 mM Zn(NO3)2$6H2O, 100 mM HMTA, 30 mM G-12, and
30 mM GT-16 were prepared as stock solutions for this study.
Prior to each reaction, equal volumes of the Zn(NO3)2$6H2O82 | J. Mater. Chem., 2011, 21, 80–89and HMTA stock solutions were mixed and predetermined
volumes of G12 or GT-16 stock solutions were added immedi-
ately to obtain final G-12 concentration or GT-16 concentration
of 0 mM, 0.03 mM, 0.15 mM and 0.30 mM, respectively. The pH
of the final solutions prepared was pH 6.9  0.1 regardless of the
presence of additives. Prepared solutions were incubated at 20 C
(24 hours  1 min) followed by immersion in a 65 C water bath
(72 hours  1 min). During the course of reaction, samples were
taken at selected times (1 min). The control reaction was per-
formed in triplicate in a single run. Collected samples were
centrifuged at 13 000 rpm for 3 minutes to separate any precip-
itate from the supernatant. The supernatant obtained was re-
centrifuged using the same conditions before being sampled into
acidified water for the determination of Zn2+ concentration,
[Zn2+], using ICP-OES (Perkin Elmer Optima 2100DV). The
precipitates were washed three times thoroughly with ddH2O.
Cleaned precipitates were lyophilized at 70 C using a Virtis-
110 freeze-dryer.Characterization of lyophilized ZnO precipitates
The wurtzite phase of ZnO was confirmed using XRD (PAN-
alytical X’Pert PRO, CuKa radiation with wavelength of 1.54056
A). Ground samples (if necessary) packed into an aluminium
sample holder were scanned for 2q from 5 to 70 at 45 kV
accelerating voltage, 40 mA filament current, using a scan speed
of 0.02 s1 at room temperature. Diffraction patterns were
analyzed using X’Pert-HighScore Plus (version 2.0a) program
for diffractogram manipulation, background determination and
peak identification. The morphology and size of the ZnO crystals
of selected precipitates were studied using SEM (JEOL JSM-
840A, 20 kV, gold sputter-coated samples). For size analysis, at
least 50 crystals were studied and the aspect ratio (L/D ¼ length/
average diameter) of each individual crystal was determined.
FTIR (Nicolet Magna IR-750, 256 scans, 2 cm1 resolution) was
used to detect ZnO, peptides, and any incorporated species in the
precipitates with a pure KBr disk being used for the background.
The amount of non-ZnO component (peptide) in the precipitates
was determined by TGA (Mettler Toledo TGA/SDTA 851e)
where samples were heated at 10 min1 from 30 C to 900 C in
air to ensure complete combustion of all organic material.Peptide adsorption studies
The selective adsorption of G-12 and GT-16 on the (0001) and
(1010) planes of ZnO was studied at 25 C using oriented ZnO
films (9 cm2) grown on silicon wafers by the ALD technique.
This temperature was chosen to minimize any change of peptide
concentration during the experiment arising from experimental
factors (only small film sizes could be prepared by ALD such that
the concentration of zinc in solution was necessarily very low)
other than direct binding. The crystal orientation of ZnO films is
controlled by its deposition temperature: 280 C and 165 C
being used for the (0001) and (1010) planes respectively.85 The
as-grown ZnO films were annealed at 800 C (1 hour) prior to the
confirmation of crystal orientation by XRD. All substrates
studied, ZnO films, silicon wafers, and glass slide, were cleaned
with acetone, dried in air, and placed into 12 mL peptide solutionThis journal is ª The Royal Society of Chemistry 2011
Fig. 1 The average and standard deviation (error bar) of Zn2+ consumed
(in %) with time in the absence of additives (n ¼ 3). The inset shows the
diffraction peaks from precipitates collected after 24 hours (t20 C ¼ 24 h)
and 25 hours (t20 C ¼ 24 h, t65 C ¼ 1 h). The diffraction peak marked
with an asterisk arises from the aluminium sample holder.
Fig. 2 SEM images for precipitates collected in the absence of additives
after (a) 24 hours (t20 C ¼ 24 h), (b) 25 hours (t20 C ¼ 24 h, t65 C ¼ 1 h),
(c) 48 hours (t20 C ¼ 24 h, t65 C ¼ 24 h), and (d) 72 hours (t20 C ¼ 24 h,
t65 C ¼ 48 h). Scale bars are 5 mm.prepared in PBS (phosphate buffered saline, 50 mM phosphate
and 150 mM NaCl, pH 7.0). Given the calculated planar Zn atom
density on (0001) and (1010) planes of ZnO crystals are 10.94
atoms per nm2 and 5.91 atoms per nm2 respectively,86 the number
of peptide molecules added were 5 times the estimated number of
Zn atoms present on the ZnO films (peptide-to-Zn ratio ¼ 5). At
predetermined incubation times (t ¼ 0, 5 hours), aliquots were
sampled from the peptide solution and assayed using the Micro-
BCA (Bicinchoninic acid) method for peptide concentration
(Thermo Fisher Scientific). The absorbance of aliquots from the
assays was measured at 562 nm using a Unicam UV2 UV-VIS
spectrometer and compared against a series of calibration
peptide solutions (0–10.5 mM), prepared in the same medium.
Adsorption tests were performed in independent triplicates. At
the end of the adsorption test, ZnO films were cleaned with
ddH2O and air-dried at room temperature before being analyzed
by XPS using a Kratos AXIS ULTRA with a monochromated
Al-Ka X-ray source (1486.6 eV) operated at a 10 mA emission
current and 10 kV anode potential (100 W). The pressure of the
analysis chamber was 3  109 torr. A wide scan (10 minutes)
and high resolution scans (10, 5, 20 and 5 minutes for Zn, O, N,
and C respectively) were performed on each sample where the
latter was charge-corrected to the hydrocarbon C1s peak (285
eV) and then quantified to compare the amounts of the relevant
elements present using Kratos sensitivity factors. The pass
energies for the wide scan and the high resolution scan were 80
eV and 20 eV respectively. Fresh ZnO films (not exposed to
peptide solution), G-12, and GT-16 were also analyzed and used
as references. Six areas were analyzed for the selected samples.
Computational calculations
A molecular dynamics (MD) simulation tool, GROMACS,87 was
used to computationally determine the stable configurations of
G-12 and GT-16 in water. The energy of the peptides was
minimized in explicit single point charge (SPC) water at 300 K
with a time step of 2 fs and total simulation time of 2 ns using the
OPLS-AA-(L)-all atom force field. Using the stable configura-
tions obtained, the interactions of G-12 and GT-16 with the
(0001) and (1010) planes of ZnO were studied in vacuum using
the Materials Studio4.3 Adsorption Locator module based on
the Metropolis Monte Carlo algorithm.88 The adsorption modes
and adsorption energies of G-12 and GT-16 on these ZnO planes
were studied and the adsorbing segments/moieties were
identified.
Results and discussion
Understanding the anisotropic growth of ZnO in the absence of
peptides
For comparison purposes, the ZnO-forming reaction used by
Tomczak et al.46 was adopted in this study. In brief, solutions of
Zn(NO3)2–HMTA were incubated initially at 20
C for 24 hours
followed by raising the temperature of the reaction medium to
65 C, where samples were taken and the progress of reaction
monitored using analytical methods to measure the amount of
Zn2+ remaining in solution, XRD to assess any crystalline phases
present and SEM to analyse the morphology of the products. In
the absence of the peptides, a gel-like intermediate compoundThis journal is ª The Royal Society of Chemistry 2011was formed at 20 C, which was found to be neither ZnO nor
pure Zn(NO3)2$6H2O (ESI, Fig. S1†). ZnO was first detected by
XRD at 1 hour (first sampling at 65 C) after the reaction
temperature was increased to 65 C (t20 C ¼ 24 h, t65 C ¼ 1 h),
Fig. 1 inset. The diffraction peaks obtained can be indexed to the
hexagonal wurtzite structure of ZnO (JCPDS card no. 36-1451).
At 65 C, the amount of Zn2+ consumed for ZnO formation
steadily increased from the stable level of 10% at 20 C until an
equilibrium state was reached when 60% of Zn2+ was reacted,
Fig. 1. The non-ZnO gel-like precipitates collected after 24 hours
(t20 C ¼ 24 h) appeared to be continuous sheets with rough
surfaces (Fig. 2a) as opposed to hexagonal ZnO crystals obtained
at 65 C (Fig. 2b–d). The absence of a centre of inversion in the
wurtzite structure is known to result in ZnO having inherent
asymmetry along its c-axis.1 In this study, the anisotropic growth
of ZnO crystals was clearly observed through the increase of
crystal aspect ratio (L/D  standard error) from 2.7  0.1 toJ. Mater. Chem., 2011, 21, 80–89 | 83
11.4  0.2 for crystals collected after 25 hours (t20 C ¼ 24 h,
t65 C ¼ 1 h, Fig. 2b) and 48 hours (t20 C ¼ 24 h, t65 C ¼ 24 h,
Fig. 2c) respectively. Oriented attachment of ZnO rods along
their c-axes was observed as the reaction was prolonged, Fig. 2d.
This phenomenon, believed to be driven by surface energy
reduction, has also been described in other publications,
however, its cause is still debated.39,76,89–93 Since ZnO was not
detected at 20 C, for simplicity, the reaction time is quoted as the
reaction duration at 65 C in all following sections, i.e. total
reaction time of 25 hours and 48 hours are described as t65 C ¼ 1
h and t65 C ¼ 24 h respectively.Fig. 4 The FTIR (a–d) and TGA (e) analyses of ZnO precipitates
collected at t65 C¼ 24 h, produced in the presence of G-12 and GT-16. (a)
The FTIR spectra of precipitates obtained in the presence of GT-16. TheZnO aspect ratio reduction by G-12 and GT-16
The addition of G-12 or GT-16 affected neither the Zn2+
consumption rate for ZnO formation nor the [Zn2+] at equilib-
rium compared to the control reaction (ESI, Fig. S2†), suggesting
that G-12 and GT-16 may not interact with Zn2+ species in
solution. These data also suggest that the presence of these two
peptides, for the concentration ranges used, does not affect
nucleation. Similar to the control reactions, ZnO crystals were
detected by XRD from precipitates collected at t65 C ¼ 1 h,
produced in the presence of G-12 and GT-16 (ESI, Fig. S3†). As
anticipated, a reduction of crystal L/D as a function of peptide
concentration was observed in the presence of GT-16 and G-12,
Fig. 3. However, the effect was more prominent for GT-16
compared to G-12, Fig. 3a. This effect induced by G-12 and GT-
16 started from the early stage of crystal growth (t65 C ¼ 1 h)Fig. 3 (a) The average and 95% confidence interval of ZnO aspect ratio
(L/D) as a function of peptide concentration, and SEM images of ZnO
crystals formed after t65 C¼ 24 h in the presence of (b) 0.03 mM G-12, (c)
0.30 mM G-12, (d) 0.03 mM GT-16, and (e) 0.30 mM GT-16. Scale bars
are 2 mm.
peak area ratio between samples (in the presence of peptides) and
the control for peak area under (b) amide-I and amide-II bands (1480–
1730 cm1), and (c) nitrate peak (1384 cm1). (d) The amide bands-to-
nitrate peak area ratio within individual spectra as depicted in (a). (e) The
weight loss attributed to the decomposition of the organic component
(200–600 C) where the error bar is the standard deviation for the control
reactions (0 mM peptide, n ¼ 3).
84 | J. Mater. Chem., 2011, 21, 80–89where the L/D was 1.0–1.7 compared to 2.7 for the control.
Compared to the L/D reduction reported for GT-16,46 the level of
L/D reduction in this study was slightly higher at lower [GT-16]
but these values converged as [GT-16] was increased.
ZnO precipitates (t65 C ¼ 24 h) obtained in the presence of
G-12 and GT-16 contain peptides as shown by the presence of
the amide-I (1600–1700 cm1) and amide-II (1500–1600 cm1)
bands in their FTIR spectra (Fig. 4a for GT-16 and ESI, Fig. S4†
for G-12). The area under the two amide bands of these FTIR
spectra was determined and normalized against the area under
the control spectrum for the same frequency range. As shown in
Fig. 4b, the amount of peptide incorporated in ZnO precipitates
increased with the initial peptide concentration, supporting the
coprecipitation of peptides with ZnO.
The presence of NO3
 (1384 cm1, asymmetric stretch)44,59,94,95
was also detected in all 48 hour precipitates including the control
(Fig. 4a), and the gel-like intermediate compound produced after
24 hours (t20 C ¼ 24 h) from the blank (ESI, Fig. S1†). The
normalized area of the nitrate peak increased linearly as a func-
tion of peptide concentration, Fig. 4c, suggesting that NO3
 ions
may have formed a complex with, possibly, the cationic moieties
of the peptide and co-precipitated with ZnO when peptides
adsorbed on ZnO surfaces. A non-constant peak area ratio of theThis journal is ª The Royal Society of Chemistry 2011
Fig. 5 The growth rate of (a) length, L, and (b) average diameter, D, of
ZnO crystals within 23 hours of reaction at 65 C, from t65 C ¼ 1 h to
t65 C ¼ 24 h. (c) Schematic showing the effect of increasing G-12 and
GT-16 concentrations on the length and diameter of ZnO crystals from
t65 C ¼ 1 h to t65 C ¼ 24 h. The images of ZnO crystals are scaled.amide-I and II bands to NO3
 (1384 cm1) calculated from FTIR
spectra suggests that not all cationic moieties of each peptide
molecule have reacted with NO3
, Fig. 4d. It has been suggested
that HMTA may adsorb on the (1010) plane of ZnO crystal,92
however, this possibility can be discounted in this study based on
the absence of the peak expected for adsorption of a tertiary
amine (1006 cm1) in all spectra including those from the
control reaction (ESI, Fig. S4†).
The coprecipitation of peptides with ZnO was further sup-
ported by substantial weight loss for the ZnO samples prepared
in the presence of peptides, with respect to the control reaction,
monitored using TGA (ESI, Fig. S5†). The trend of organic
component weight loss as a function of peptide concentration
(Fig. 4e) was similar to the trend shown by FTIR results in
Fig. 4b. The coprecipitation of NO3
 with ZnO (suggested by
FTIR results) did not alter the trend of the incorporated amount
of peptide significantly (ESI, Fig. S6†). Therefore while reducing
the aspect ratio of ZnO crystals, these two peptides co-precipi-
tated onto/into the ZnO crystals. Furthermore, GT-16 which was
incorporated to a greater extent than G-12, perhaps therefore has
a stronger effect on L/D reduction compared to G-12. This may
imply a correlation between the amount of peptide incorporated
and the level of L/D reduction.
There were two observations which indirectly suggest peptide
adsorption on ZnO surfaces. Firstly, a blue-shift of the amide-I
band (from ZnO-peptide precipitates) relative to the amide-I
band of the pure peptides was observed. The observed
amide-I band shift of 20–26 cm1 from 1671 cm1 was likely to be
due to the adsorption of peptides on crystal surfaces which alters
the energy of vibration.96 Secondly, a new peak at 1590–1594
cm1, assignable to the symmetric stretching of bound COO was
detected.40,97 Since both G-12 and GT-16 have no acidic amino
acid residues, the bound COO most probably arose from the
C-terminus of these peptides.Modification of ZnO growth rate by G-12 and GT-16
In order to understand how ZnO growth has been affected and
how the additional GGGC-tag of GT-16 enhanced the aspect
ratio reduction, the growth rates of individual crystal dimensions
from t65 C ¼ 1 h to t65 C ¼ 24 h were determined, namely, DL/Dt
for length along the c-axis and DD/Dt for the average diameter
along the a-axis, Fig. 5a and b.
In the absence of peptide, DL/Dt and DD/Dt for the ZnO
crystals were 149 nm h1 and 3.4 nm h1 respectively. Addition of
G-12 reduced DL/Dt gradually to 10 nm h1 as the peptide
concentration was increased. In contrast, addition of GT-16,
even at the lowest concentration (0.03 mg mL1), drastically
reduced DL/Dt to 7 nm h1, however, this growth rate was not
affected by further increase in the peptide concentration. In the
presence of GT-16, reduction in growth along the c-axis was
compensated for by an increase in DD/Dt. This contrasted with
the crystal growth observed in the presence of G-12, where the
average diameter of the ZnO crystals remained unchanged (DD/
Dt z 0) for the 23 hour analysis period regardless of the
concentration of G-12 showing that G-12 has little or no influ-
ence on the a-axis growth of the crystal. The effect of increasing
G-12 and GT-16 concentrations on the length and diameter
growth of ZnO crystals from t65 C ¼ 1 h to t65 C ¼ 24 h, asThis journal is ª The Royal Society of Chemistry 2011described above, is illustrated by a scaled schematic in Fig. 5c. In
contrast to the data presented by Tomczak et al. in their study
using GT-16 where the observed aspect ratio reduction was
reported as being due to crystal length reduction, our studies
have shown that by separately analyzing the effect of the two
peptides (G-12 and GT-16) on both the length and diameter of
the crystals formed, we have discovered that the reduction of the
ZnO aspect ratio is a combination of the presence of G-12 or
GT-16 on both the length (c-axis) and diameter (a-axis) growth
of the ZnO crystals.
Up to this point, the presence of G-12 and GT-16 has been
confirmed to reduce the c-axis growth of ZnO crystals while the
presence of G-12 has also retarded the diameter growth (a-axis)
growth of the crystal. In addition, the coprecipitation of G-12
and GT-16 strongly correlated (quantitatively) with the reduc-
tion of crystal dimension growth rate. In many instances the
presence of capping agents such as DBCP,22–25 citrate ions,19,20,75
hydroxyl ions,13 etc. has been shown to reduce the aspect ratio of
ZnO crystals. Since (0001) is a Zn-terminated plane, the capping
agents that have reduced the aspect ratio of ZnO crystals and/or
were proposed to adsorb on the (0001) plane are generally
anionic or contain anionic moiety(ies). Therefore, based on this
generally accepted rationalization, the inhibition of diameter
growth in the presence of G-12 but not with GT-16 would lead to
three possible speculations. Firstly, besides adsorbing on (0001),J. Mater. Chem., 2011, 21, 80–89 | 85
G-12 molecules were able to adsorb onto the (1010) plane of ZnO
crystals, possibly via a different adsorption mechanism.
Secondly, GT-16 selectively adsorbed onto the (0001) planes of
ZnO crystals. Thirdly, the plane selectivity of GT-16 was
attributable to the GGGC tag not present in G-12. To unravel
the cause(s) of these interesting findings, the adsorption behavior
of G-12 and GT-16 was studied.Fig. 7 The atomic % of N 1s determined using XPS (high resolution
scan). GT and G denote GT-16 and G-12 respectively. Inset shows the
peptide density on ZnO films reproduced from Fig. 6b.
Scheme 1 The adsorption–growth-inhibition mechanism. The length
and thickness of growth arrows reflects the growth rate of the crystals
along their respective axes.A comparison of the adsorption of G-12 and GT-16 on ZnO
crystal planes
The adsorption behavior of G-12 and GT-16 was studied by
exposing ALD grown-ZnO films with either (0001) or (1010)
plane (ESI, Fig. S7†) to peptide solutions. The use of oriented-
ZnO films eliminated any uncertainties of peptide adsorption
sites, which may arise from the use of ZnO crystals with more
than one surface crystallographic plane. The amount of peptide
adsorbed and peptide density on the ZnO films were determined
by a depletion method from the amount of peptide retained in
solution after 5 hours of substrate exposure. From the amount
adsorbed on the different substrates (area z 9 cm2), G-12 and
GT-16 both showed material selectivity towards ZnO over
silicon wafer and glass, Fig. 6a. Peptide density (Fig. 6b) was
typically higher on the basal plane, ZnO(0001), compared to the
side planes, Zn(1010). The inter-plane density difference for
GT-16 was 0.31 nmol cm2 as compared to 0.08 nmol cm2 for
G-12, suggesting a preferential adsorption of GT-16 on the
(0001) plane. Preferential adsorption of GT-16 supports the
observation of reduced growth rate on the c-axis (DL/Dt) but not
on the a-axis (DD/Dt) in its presence. The lower G-12 density on
the (0001) plane and its weaker plane selectivity were demon-
strated by the lower extent of ZnO aspect ratio reduction in its
presence.
Evidence for peptide adsorption on ZnO crystal planes and the
adsorption process being peptide- and crystal plane-dependent
was provided by XPS analysis which confirmed that significant
amounts of peptide were present on the ZnO films exposed to the
solutions of the peptides, Fig. 7. The presence of peptide was
confirmed via the detection of nitrogen (N 1s) with binding
energy of 400 eV. Fig. 7 shows the N 1s atomic % (high reso-
lution scan) on exposed ZnO films, unexposed ZnO films, G-12,
and also GT-16. XPS results obtained did not (quantitatively)
coincide entirely with the adsorption results, inset of Fig. 7.Fig. 6 The adsorption of G-12 and GT-16 on different substrates after 5
hours of exposure: (a) the amount adsorbed on a substrate with an area
9 cm2, and (b) peptide density. The error bars shown are the standard
deviation (n ¼ 3).
86 | J. Mater. Chem., 2011, 21, 80–89However, the important outcomes are summarized as follows: (i)
the detection of a substantial amount of nitrogen on the surface
of ZnO films (exposed to peptide solution) is direct evidence of
peptide adsorption on ZnO crystal planes, (ii) the amount of
G-12 adsorbed on the (0001) plane was slightly larger than on the
(1010) plane, which corroborated the experimental observations
(Fig. 6b), and (iii) the amount of GT-16 adsorbed on the (0001)
plane was significantly higher than G-12 on the same plane for
both ZnO planes.
The presented data show that for ZnO formation in the
presence of ZnO-BPs, both G-12 and GT-16 altered the growth
rates of ZnO crystal planes and are adsorbed on these crystal
planes, with the level of growth reduction being positively
correlated with the amount of peptide adsorbed. Therefore the
modification of ZnO crystal morphology by G-12 and GT-16
occurs via an adsorption–growth inhibition mechanism as illus-
trated in Scheme 1. Hitherto, the incorporation/adsorption of
SDAs on ZnO has been shown qualitatively by FTIR,
TGA,21,23,34 fluorescence microscopy,23,58 and SEM (through the
presence and multiplication of growth spirals in the presence ofThis journal is ª The Royal Society of Chemistry 2011
DBCPs).25 To our knowledge, this is the first study providing
unambiguous and direct quantitative experimental evidence, by
the use of ALD-grown single orientation ZnO films, for the
(selective and non-selective) adsorption-driven ZnO morphology
modification by biomolecules and specifically a ZnO-BP identi-
fied from phage display libraries.Adsorption and selective adsorption: cause and driving force
To complement the experimental data, a computational
approach was employed to provide (calculated) energetic data
and the prediction of binding moiety(ies). When exposed to ZnO
surfaces in vacuum, the adsorption modes and adsorption energy
(Eads) of stable configurations of G-12 and GT-16 (simulated in
water by MD) were determined. The adsorption of G-12 and
GT-16 on ZnO planes was found to be an energetically favorableTable 1 The prediction of bound amino acid residues of G-12 and GT-16 o
a The side chain charge at pH 6.9  0.1 (based on calculated pKa): green cell fo
of a residue that binds on different ZnO planes (based on computational predi
Fig. 8 The average adsorption energy and standard deviation of G-12
and GT-16 on (0001) and (1010) planes of ZnO. The standard deviation
was less than 5% (n ¼ 10).
This journal is ª The Royal Society of Chemistry 2011process, Fig. 8. The selective adsorption of GT-16 was self-
explanatory based on a lower Eads on the (0001) plane and
a higher inter-plane Eads of 288 kJ mol
1 as opposed to 100 kJ
mol1 for G-12. The low adsorption selectivity of G-12 can be
attributed to competition in binding arising from the smaller
difference in its inter-plane Eads, thus an additional limitation of
growth along the a-axis was observed.
Much literature has reported/proposed electrostatic interac-
tion/coordination between the Zn2+ of the (0001) plane and
additives (DBCP,23,24,98 citrate,19,20 phosphate,17 TEA,15,99 etc.) as
being responsible for the adsorption of the specific additive on
the (0001) plane. The charge and the extent of protonation/de-
protonation of amino acid residues in G-12 and GT-16 at pH 6.9
 0.1 (based on their pKa values, ESI, Fig. S8†) were determined,
and compared with the predicted binding moieties (by simulation
as shown in ESI, Fig. S9†) in Table 1.
As shown in Table 1, residues with cationic/neutral side chains
were predicted to engage on the (0001) plane of ZnO, namely H3
and K7 for G-12, and G1, H6, and K7 for GT-16. Since neutral
imidazole nitrogen atoms could coordinate with Zn2+ using
a lone pair on a nitrogen atom,100 the prediction of H3 (of G-12)
and H6 (of GT-16) binding on the (0001) plane of ZnO is not
surprising. From the FTIR spectra of peptide adsorbed-ZnO
precipitates, an absorption peak arising from the asymmetric
stretching of NO3
 (1384 cm1) was observed (Fig. 4a). The
positive correlation between the amount of NO3
 incorporated
and the amount of peptide initially present (Fig. 4c) suggests that
NO3
 interacts with the cationic moieties of G-12 and GT-16.
This interaction may reduce the repulsion between the peptide
and Zn2+ ions on ZnO crystal planes and will be applicable for
any positively charged amino acid residue present in the peptides.
The prediction of cationic G1 (of GT-16) and K7 (of G-12
and GT-16) as favorable anchor points on the also cationicn ZnO surfacesa,b
r positive, white cell for neutral, and pink cell for negative. The side chain
ction): blue circles for (0001) plane and red circles for (1010) plane. b pKb.
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Zn-terminated (0001) plane was unexpected although the
significance of K7 in binding to ZnO surfaces has recently been
shown by other experimentalists using the ZnO-BP EM12.73 It is
speculated that the R12 and C16 of G-12 and GT-16 respectively
are able to bind to Zn2+ on the (0001) plane. The higher GT-16
density measured on the (0001) plane (adsorption test) may arise
due to (i) higher binding capacity of H6 (>50% neutral side chain)
from GT-16 as opposed to 50% neutral H3 of G-12, and (ii)
stronger binding of GT-16 through C16 via its C-terminal COO

and its thiol sulfur which is able to bridge two Zn2+ ions.101
In comparison with peptide binding on the (0001) plane, the
predicted binding residues on the (1010) plane are very different
for G-12 and GT-16. The predicted binding moieties from G-12
are polar (H3 and K7) but largely non-polar for GT-16 (M5, R12,
and GGGC-tag). Due to the presence of both Zn2+ and O2 on
the (1010) plane, cationic H3 and K7 are suggested to interact
with O2 via electrostatic interactions while neutral H3 could
coordinate with Zn2+ ions or hydrogen bond with O2 ions. The
adsorption of GT-16 on the (1010) plane may occur via hydrogen
bonding (neutral R12 with O
2), electrostatic interactions (thiol
and COO of C16 with Zn
2+, and M5 sulfur atom lone pair with
Zn2+), and hydrophobic interactions (via the GGG-segment).
Inferred from these differences, the presence of the GGGC-tag
may have lowered the GT-16 density on the (1010) plane due to
a weaker hydrophobic adsorption contribution. In short, the
calculation of adsorption energies and the prediction of binding
moieties using a computational approach have provided a plau-
sible explanation for the adsorption phenomenon observed.Conclusions
A ZnO-BP (G-12) identified by Phage display methods and its
-GGGC tagged derivative (GT-16) both affect ZnO crystal
morphology in a concentration dependent fashion by altering the
c-axis and a-axes growth rate of ZnO crystals. As a consequence,
the aspect ratio of ZnO was reduced in their presence with the
effect being more prominent in the presence of GT-16. For the
first time, the amount of peptide adsorbed on different ZnO
crystal planes has been quantified by a depletion method using
ALD-grown oriented ZnO films. In conjunction with the
confirmation of adsorption by XPS, this study has provided
direct evidence for the modification of ZnO morphology via an
adsorption–growth inhibition mechanism in the presence of
ZnO-BP and its derivative. The correlation of peptide adsorption
behavior with the alteration of crystal plane growth rates verified
the preferential binding (discriminative behavior) of GT-16 on
the (0001) plane over the (1010) plane of ZnO crystals. Such
behavior was not evident for G-12 which lacked the GGGC-tag,
indicating that the GGGC-tag present in GT-16 was not essential
for peptide adsorption on the (0001) plane of ZnO but provided
GT-16 with plane selectivity characteristics. The calculated
adsorption energies of G-12 and GT-16 on different ZnO planes
were in broad agreement with the level of plane-selectivity shown
experimentally. A prediction of binding moieties by a computa-
tional (MD) approach identified GGGC as being the cause of the
plane selectivity behavior of GT-16.
The tuning of ZnO morphology via biomolecule adsorption is
a complex phenomenon. The solution chemistry of amino acid
residues, the nature of counterions, the surface chemistry of ZnO88 | J. Mater. Chem., 2011, 21, 80–89planes, and peptide sequences were all found to play a part and
influenced the reaction. The total elucidation of this complex
phenomenon would require further extensive studies. However,
the results reported in this contribution provide evidence and
insight into ZnO morphology-tuning, mediated by the adsorp-
tion of biomolecules on specific crystal plane(s) of ZnO crystals.
The ultimate goal of these studies is to identify and understand
the specific role(s) individual functionalities play within a given
biomolecule in ZnO morphology tuning. By doing so, the spec-
ificity and multi-functionality of biomolecules in affecting ZnO
morphology can be learnt and manipulated to tailor-make ZnO
crystals with controllable morphology and properties.Acknowledgements
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